U.S. - Biological Products - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingBiological Product Prices in the United States
U.S. Biological Product Import Price per Ton in June 2022
In June 2022, the biological product price per ton amounted to $2.6M (CIF, US), with an increase of 78% against the previous month. Over the period under review, the import price saw significant growth. As a result, import price attained the peak level and is likely to continue growth in the immediate term.
There were significant differences in the average prices amongst the major supplying countries. In June 2022, the country with the highest price was Ireland ($34.5M per ton), while the price for Poland ($11.6K per ton) was amongst the lowest.
From January 2022 to June 2022, the most notable rate of growth in terms of prices was attained by Canada (+39.0%), while the prices for the other major suppliers experienced more modest paces of growth.
U.S. Biological Product Imports
In July 2022, the amount of biological products imported into the United States shrank slightly to 1.7K tons, declining by -3.7% against June 2022. Overall, imports faced a abrupt decrease. The pace of growth appeared the most rapid in May 2022 when imports increased by 14% month-to-month.
In value terms, biological product imports contracted markedly to $3.7B (IndexBox estimates) in July 2022. Over the period under review, imports continue to indicate a abrupt shrinkage. The growth pace was the most rapid in May 2022 with an increase of 22% month-to-month.
U.S. Biological Product Imports by Country
In June 2022, Canada (649 tons) constituted the largest supplier of biological product to the United States, with a 37% share of total imports. Moreover, biological product imports from Canada exceeded the figures recorded by the second-largest supplier, Germany (198 tons), threefold. China (126 tons) ranked third in terms of total imports with a 7.3% share.
From January 2022 to June 2022, the average monthly rate of growth in terms of volume from Canada totaled -8.2%. The remaining supplying countries recorded the following average monthly rates of imports growth: Germany (-0.3% per month) and China (-47.3% per month).
In value terms, Ireland ($1.7B) constituted the largest supplier of biological product to the United States, comprising 36% of total imports. The second position in the ranking was taken by Germany ($450M), with a 9.8% share of total imports. It was followed by Switzerland, with an 8.6% share.
From January 2022 to June 2022, the average monthly rate of growth in terms of value from Ireland stood at +5.8%. The remaining supplying countries recorded the following average monthly rates of imports growth: Germany (-6.0% per month) and Switzerland (-1.8% per month).
This report provides an in-depth analysis of the biological product market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202120 -
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
- Prodcom 21202160 - Vaccines for veterinary medicine
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
- Prodcom 21202320 - Blood-grouping reagents
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2024
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2024
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Per Capita Consumption In 2012-2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
- Trade Balance, In Physical Terms, 2012-2024
- Trade Balance, In Value Terms, 2012-2024
- Per Capita Consumption, 2012-2024
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2024
- Production, In Value Terms, 2012–2024
- Imports, In Physical Terms, 2012–2024
- Imports, In Value Terms, 2012–2024
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, 2012–2024
- Exports, In Value Terms, 2012–2024
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
535
This report provides an in-depth analysis of the biological product market in the U.S..
438
This report provides an in-depth analysis of the antisera market in the U.S..
465
This report provides an in-depth analysis of the vaccine market in the U.S..
331
This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S..
390
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
427
This report provides an in-depth analysis of the global biological product market.
1982
This report provides an in-depth analysis of the global antisera market.
2592
This report provides an in-depth analysis of the global vaccine market.
645
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
496
This report provides an in-depth analysis of the global market for human and animal blood.
116
Haleon invests $54M in its U.S. R&D centre to drive innovation in consumer healthcare, enhancing its product pipeline and maintaining competitive edge.
598
For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by...
117
U.S. experts predict a smaller winter COVID wave, posing challenges for Pfizer amid declining revenues, emphasizing the need to diversify non-COVID products.
243
Explore Moderna's ongoing phase three norovirus vaccine trial targeting urgent prevention needs amid rising outbreaks in the U.S.
210
Moderna has secured $590 million to enhance pandemic influenza vaccine development, focusing on mRNA technology and expanding human trials.
94
Moderna's shares increased by over 10% due to progress in H5N1 vaccine development following a human fatality in the U.S.
68
In the period of 2018 to 2024, the growth of exports for Human And Animal Blood failed to regain momentum. The value of exports declined to $3.5B in 2024.
1359
From February 2023 to December 2023, the exports of Human And Animal Blood saw a significant decline, dropping to $71M in value.
474
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
84
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
